Nuo Wang
Changsha, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
RNA aptamers with specific binding affinity to CD40 (CD40Apt) represents a promising antagonist of the CD40-CD40L signaling for thyroid-associated ophthalmopathy (TAO) treatment in mouse.
Journal: Journal of translational medicine
Published: September 28, 2022
A cause-effect relationship between Graves' disease and the gut microbiome contributes to the thyroid-gut axis: A bidirectional two-sample Mendelian randomization study.
Journal: Frontiers in immunology
Published: June 24, 2022
The miR-103a-3p/TGFBR3 axis regulates TGF-β-induced orbital fibroblast activation and fibrosis in thyroid-eye disease.
Journal: Molecular and cellular endocrinology
Published: April 21, 2022
LncRNA LPAL2/miR-1287-5p/EGFR Axis Modulates TED-Derived Orbital Fibroblast Activation Through Cell Adhesion Factors.
Journal: The Journal of clinical endocrinology and metabolism
Published: January 31, 2021
Epigenetics effect on pathogenesis of thyroid-associated ophthalmopathy.
Journal: International journal of ophthalmology
Published: November 01, 2020
Overview of Graves Ophthalmopathy Literature From 1999 to 2019: Bibliometric Analysis.
Journal: Interactive journal of medical research
Published: October 07, 2020
Phacoemulsification with or without goniosynechialysis for angle-closure glaucoma: a global Meta-analysis based on randomized controlled trials.
Journal: International journal of ophthalmology
Published: November 24, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026